Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Risk of Urothelial Cancers”

64 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 64 results

Not applicableLooking for participantsNCT06991868
What this trial is testing

Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD)

Who this might be right for
NMIBCMIBCUTUC
Peking University First Hospital 300
Not applicableUnknownNCT04994197
What this trial is testing

Urothelial Tumor Risk Genes Detection With Genetron Uro V1 and LC-WGS

Who this might be right for
Urothelial Carcinoma
Ruijin Hospital 970
Testing effectiveness (Phase 2)Looking for participantsNCT05394337
What this trial is testing

Neoadjuvant PD-1 Plus TIGIT Blockade in Patients With Cisplatin-Ineligible Operable High-Risk Urothelial Carcinoma

Who this might be right for
Metastatic Malignancy
M.D. Anderson Cancer Center 10
Large-scale testing (Phase 3)Ended earlyNCT02450331
What this trial is testing

Atezolizumab Versus Observation as Adjuvant Therapy in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (UC) After Surgical Resection

Who this might be right for
Carcinoma, Transitional Cell
Hoffmann-La Roche 809
Not applicableUnknownNCT04943380
What this trial is testing

Efficacy and Utility of Cxbladder Tests in Hematuria Patients

Who this might be right for
HematuriaUrothelial Carcinoma
Pacific Edge Limited 684
Large-scale testing (Phase 3)Study completedNCT05136898
What this trial is testing

Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
Bladder CancerUrothelial CarcinomaUrothelial Carcinoma Bladder
UroGen Pharma Ltd. 8
Testing effectiveness (Phase 2)Study completedNCT03914794
What this trial is testing

Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors

Who this might be right for
Bladder CancerNMIBCNon-Muscle Invasive Bladder Cancer+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 30
Testing effectiveness (Phase 2)Study completedNCT04311580
What this trial is testing

Intravesical Electromotive Mitomycin After Bacillus Calmette-Guérin Failure

Who this might be right for
Bladder Cancer
University of Rome Tor Vergata 52
Not applicableStudy completedNCT03514888
What this trial is testing

HIPEC After Radical Cystectomy for High Risk Bladder Cancer

Who this might be right for
Invasive Bladder Cancer
Weill Medical College of Cornell University 7
Not applicableLooking for participantsNCT03973671
What this trial is testing

Prospective Sample Collection for Cancer of Bladder

Who this might be right for
Urinary Bladder Neoplasms
Universitaire Ziekenhuizen KU Leuven 300
Not applicableUnknownNCT00867620
What this trial is testing

Development of a Non-Invasive DNA Methylation-Based Assay System for the Risk Assessment of Urothelial Carcinoma

Who this might be right for
Bladder Cancer
National Taiwan University Hospital 82
Not applicableLooking for participantsNCT05646485
What this trial is testing

Bladder Cancer Screening Trial

Who this might be right for
Bladder CancerUrothelial CarcinomaHematuria+1 more
University of Texas Southwestern Medical Center 1,000
Not applicableLooking for participantsNCT05463796
What this trial is testing

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Who this might be right for
Cancer RiskCancer Predisposition SyndromeHereditary Cancer Prediction+28 more
Dana-Farber Cancer Institute 5,000
Large-scale testing (Phase 3)Active Not RecruitingNCT06111235
What this trial is testing

Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT

Who this might be right for
Non Muscle Invasive Bladder CancerUrologic CancerBladder Cancer+1 more
CG Oncology, Inc. 367
Testing effectiveness (Phase 2)WithdrawnNCT06050954
What this trial is testing

A Pilot Study of Circulating Tumor DNA Adaptive Risk Maintenance Approach for Bladder Cancer (CARMA)

Who this might be right for
Metastatic Urothelial Carcinoma
Fox Chase Cancer Center
Large-scale testing (Phase 3)Looking for participantsNCT05037279
What this trial is testing

Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients with Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC)

Who this might be right for
Bladder CancerBladder Cancer RecurrentNeoplasm Recurrence+3 more
Verity Pharmaceuticals Inc. 540
Testing effectiveness (Phase 2)Study completedNCT01031420
What this trial is testing

Dose Dense MVAC for Muscle Invasive Bladder Cancer

Who this might be right for
Muscle Invasive Bladder CancerHigh Risk Urothelial Carcinoma of the Upper Urinary Tracts
Fox Chase Cancer Center 54
Not applicableUnknownNCT03230201
What this trial is testing

Lymph Node Dissection in High-risk UTUC(Upper Tract Urothelial Carcinoma)

Who this might be right for
RecurrenceMetastasisUpper Tract Urothelial Carcinoma+1 more
Peking University First Hospital 80
Not applicableNot Yet RecruitingNCT06907095
What this trial is testing

Cohort Evaluation of Body Fluids Early Detection of Cancer in High-risk Individuals

Who this might be right for
Risk of Breast CancerRisk of Gynaecological CancerRisk of Colorectal Cancer+14 more
Gustave Roussy, Cancer Campus, Grand Paris 5,909
Testing effectiveness (Phase 2)Study completedNCT03558503
What this trial is testing

A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder CancerUrothelial CarcinomaUrothelial Carcinoma Bladder
UroGen Pharma Ltd. 63
Load More Results